S

Swiss Tropical and Public Health Institute

Updated 7 Aug 2026
Own this investor? Claim the page to unlock editing and verified-owner badge.

A leading global health research institute associated with the University of Basel, focusing on infectious diseases and health systems in low-resource settings.

Funder analysis

Web-researched analysis· 3 Aug 2026· v7

Investment thesis

Swiss TPH exists to generate scientific evidence and create solutions that improve global health in low-resource settings, translating research into action across 120 countries [1].

  • It operates as an independent public-law institution associated with the University of Basel, blending academic excellence with field implementation [2].
  • The institute’s strategic agenda prioritizes infectious diseases (malaria, NTDs, HIV), health systems strengthening, and implementation science [1][2].
  • It functions as a hub for capacity building and education, offering degrees in epidemiology and infection biology to train the next generation of global health leaders [2].
  • Funding is heavily reliant on competitive grants (76% of income), indicating a mission-driven model dependent on external validation and project-based success [3].
Credibility: The institute’s structure as a public-law entity and its 80-year history of generating peer-reviewed evidence (500 publications/year) anchor its operational mandate [1][2].

Value add

Engaging with Swiss TPH provides access to unparalleled field expertise, diagnostic capabilities, and a global network in LMICs.

  • Fit verdict: Ideal for founders in diagnostics, vaccines, or health tech seeking rigorous field validation, clinical trial infrastructure, and implementation science expertise in low-resource settings.
  • Founder diligence script:
1. Does my technology align with their current focus on NTDs, malaria, or health systems strengthening? 2. Can I propose a collaborative research project or clinical trial that leverages their Diagnostic Centre or field offices? 3. Are they a suitable consortium partner for a larger grant bid from SNSF, EU, or foundations? 4. What are the IP and data-sharing terms for collaborative research or diagnostic services?

Portfolio focus

Swiss TPH’s work clusters around infectious diseases, health systems, and implementation science.

  • Soil-transmitted helminthiasis control and elimination, involving global advisory committees and field studies [4].
  • Malaria research, including vaccine development and epidemiology [1].
  • HIV/AIDS and tuberculosis interventions, often in partnership with global health organizations [1].
  • Health systems strengthening and policy advice, providing strategic and operational support to governments and NGOs [2].
  • Climate-driven health risks and environmental health, addressing emerging global health challenges [1].

Sources

  1. swisstph.ch
  2. en.wikipedia.org
  3. icinga.com
1 more source
  1. dx.plos.org

Co-investors

No co-investors named in this fund's research yet.

Signals & partners focus areas · graph signals · limited partners

Overview

infectious diseasesneglected tropical diseasesmalariaHIV/AIDSvaccine developmentenvironmental healthhealth systems strengtheningimplementation science